Left Atrial Appendage Exclusion for Atrial Fibrillation

Faisal F Syed1, Christopher V DeSimone1, Paul A Friedman1

  • 1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

Heart Failure Clinics
|March 13, 2016
PubMed

Insights

Percutaneous left atrial appendage closure offers stroke prevention for atrial fibrillation patients unable to use anticoagulants. This review covers surgical and device-based methods, stroke risks, and procedural considerations.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Stroke Prevention

Background:

  • Atrial fibrillation (AF) increases stroke risk, particularly from the left atrial appendage (LAA).
  • Anticoagulant therapy is standard but contraindicated in some AF patients.
  • Left atrial appendage closure is an alternative stroke prevention strategy.

Purpose of the Study:

  • To review current surgical and percutaneous left atrial appendage closure techniques.
  • To discuss stroke mechanisms in AF and the role of LAA.
  • To compare procedural approaches and clinical management.

Main Methods:

  • Review of published studies on LAA closure.
  • Focus on stroke mechanisms, LAA anatomy and function.
  • Analysis of procedural techniques and clinical outcomes.

Main Results:

  • Various percutaneous and surgical LAA closure devices and methods exist.
  • Understanding LAA structure and function is crucial for effective stroke prevention.
  • Procedural nuances and patient management strategies vary.

Conclusions:

  • Left atrial appendage closure is a growing option for stroke risk reduction in specific AF populations.
  • Further research and standardization of techniques are ongoing.
  • This review provides a comprehensive overview for clinicians.

Related Concept Videos